Involvement of caspase-3 and GD3 ganglioside in ceramide-induced apoptosis in Farber disease

Journal of Histochemistry and Cytochemistry

Volumn 48, Issue 1, 2000, Pages 57-62

  Farina, Felicia ^a   Cappello, Francesco ^a   Todaro, Matilde ^a   Bucchieri, Fabio ^a   Peri, Giovanni ^a   Zummo, Giovanni ^a   Stassi, Giorgio ^a,b  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Active caspase 3; Apoptosis; Caspases; Farber disease; GD3 ganglioside; K18

Indexed keywords

ACYLSPHINGOSINE DEACYLASE; CASPASE 3; CERAMIDE; GANGLIOSIDE GD3;

ADULT; APOPTOSIS; ARTICLE; CASE REPORT; CELL DESTRUCTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; FARBER DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0033985056     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1177/002215540004800106     Document Type: Article

References (34)

1. Abenoza P, Sibley RK (1987) Farber's disease: a fine structural study. Ultrastruct Pathol 11:397-403
2. Anjum R, Ali AM, Begum Z, Vanaja J, Khar A (1998) Selective involvement of caspase-3 in ceramide induced apoptosis in AK-5 tumor cells. FEBS Lett 439:81-84
3. Ballou LR, Laulederkind SJF, Rosloniec EF, Raghow R (1996) Ceramide signalling and the immune response. Biochim Biophys Acta 1301:273-278
4. Burck U, Moser HW, Goebel HH, Grutter R, Held KR (1985) A case of lipogranulomatosis Farber: some clinical and ultrastructural aspects. Eur J Pediatr 143:203-208
5. Caulìn C, Salvesen GS, Oshima R (1997) Caspase cleavage of keratin 18 and reorganization of intermediate filament during epithelial cell apoptosis. J Cell Biol 138:1379-1394
6. Charelut M, Feunteun J, Harzer K, Fensom AH, Basile JP, Salvayre R, Levade T (1996) A simple method for screening for Farber disease on cultured skin fibroblasts. Clin Chim Acta 245:61-71
7. Chen WW, Decker GL (1982) Abnormalities of lysosomes in human diploid fibroblasts from patients with Farber's disease. Biochim Biophys Acta 718:185-192
8. Cifone MG, Roncaioli P, De Maria R, Camarda G, Santoni A, Ruberti G, Testi R (1995) Multiple pathways originate at the Fas/ APO-1 (CD95) receptor: sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. EMBO J 14:5859-5868
9. De Maria R, Lenti L, Malisan F, D'Agostino F, Tomassini B, Zeuner A, Rippo MR, Testi R (1997) Requirement for GD3 ganglioside in CD95-and ceramide-induced apoptosis. Science 277: 1652-1655
10. De Maria R, Rippo MR, Schuchman ES, Testi R (1998) Acidic sphingomyelinase is necessary for Fas-induced GD3 ganglioside accumulation and efficient apoptosis of lymphoid cells. J Exp Med 187:897-902
11. Fujiwaki T, Hamanaka S, Koga M, Ishihara T, Nishikomori R, Kinoshita E, Furusho K (1992) A case of Farber disease. Acta Paediatr Jpn 34:72-79
12. Genestier L, Prigent AF, Paillot R, Quemeneur L, Durand I, Banchereau J, Revillard JP, Bonnefoy Bérard N (1998) Caspase-dependent ceramide production in Fas-and HLA class I-mediated peripheral T cell apoptosis. J Biol Chem 273:5060-5066
13. Giordano C, Stassi G, De Maria R, Todaro M, Richiusa P, Papoff G, Rubert G, Bagnasco M, Testi R, Galluzzo A (1997) Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275:960-963
14. Green DR, Reed JC (1998) Mitochondria and apoptosis. Science 281:1309-1312
15. Haraoka G, Muraoka M, Yoshioka N, Wakami S, Hayashi I (1997) First case of surgical treatment of Father's disease. Ann Plast Surg 39:405-410
16. Koch J, Gartner S, Li C, Quintern LE, Bernardo K, Levran O, Schnabel D, Desnick RJ, Schuchman E, Sandhoff K (1996) Molecular cloning and characterization of a full-length complementary DNA encoding human acid ceramidase. J Biol Chem 271: 33110-33115
17. Koga M, Ishihara T, Uchino F, Fujiwaki T (1992) An autopsy case of Farber's lipogranulomarosis in a Japanese boy with gastrointestinal involvement. Acta Pathol Jpn 42:42-48
18. Leers MPG, Kölgen W, Björklund B, Bergman T, Tribbick G, Persson B, Björklund P, Ramaekers FCS, Björklund B, Nap M, Jörnval H, Schutte B (1999) Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol 187:567-572
19. Levade T, Moser HW, Fensom AH, Harzer K, Moser AB, Salvayre R (1995) Neurodegenerative course in ceramidase deficiency (Farber disease) correlates with the residual lysosomal ceramide turnover in cultured living patient cells. J Neurol Sci 134:108-114
20. Moser HM (1997) Ceramidase deficiency: Farber lipogranulomatosis. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York, McGraw-Hill, 820-830
21. Nowaczyk MJM, Feigenbaum A, Silver MM, Callahan J, Levin A, Jay V (1996) Bone marrow involvement and obstructive jaundice in Farber lipogranulomatosis: clinical and autopsy report of a new case. J Inher Metab Dis 19:655-660
22. Patel T, Gores GJ, Kaufmann SH (1996) The role of proteases during apoptosis. FASEB J 10:587-597
23. Qualman SJ, Moser HW, Valle D, Moser AE, Antonarakis SE, Boitnott JK, Zinkham WH (1987) Farber disease: pathologic diagnosis in sibs with phenotypic variability. Am J Med Genet Suppl 3:233-241
24. Schwartz SM (1998) Cell death and caspase cascade. Circulation 97:227-229
25. Spicer SS (1987) Histochemistry in pathologic diagnosis. In Schwartz ME, ed. Clinical and Biochemical Analysis. Vol 22. New York, Marcel Dekker
26. Stassi G, Todaro M, Bucchieri F, Stoppacciaro A, Farina F, Zummo G, Testi R, De Maria R (1999) Fas/Fas ligand-driven T cell apoptosis as a consequence of ineffective thyroid immunoprivilege in Hashimoto's thyroiditis. J Immunol 162:263-267
27. Stassi G, Todaro M, De Maria R, Candore G, Cigna D, Caruso C, Galluzzo A, Giordano C (1997a) Defective expression of CD95 (FAS/APO-1) molecule suggests apoptosis impairment of T and B cells in HLA-B8, DR3-positive individuals. Hum Immunol 55:39-45
28. Stassi G, De Maria R, Trucco G, Rudert W, Testi R, Galluzzo A, Giordano C, Trucco M (1997b) Nitric oxide primes pancreatic b-cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J Exp Med 186:1193-1200
29. Tanaka T, Takahashi K, Hakozaki H, Kimoto H, Suzuki Y (1979) Farber's disease (disseminated lipogranulomatosis) a pathological, histochemical and ultrastructural study. Acta Pathol Jpn 29:135-155
30. Tepper AD, Boesen-de Cock JGR, de Vries F., Borst J, van Blitterswijk WJ (1997) CD95/Fas-induced ceramide formation proceed with slow kinetics and is not blocked by caspase-3/CCP32 inhibition. J Biol Chem 272:24308-24312
31. Tesri R (1996) Sphingomyelin breakdown and cell fate. Trends Biol Sci 21:468-471
32. Thornberry NA, Lazebnik (1998) Caspases: enemies within. Science 281:1312-1316
33. Van Echten Deckert G, Klein A, Linke T, Heinemann T, Weisgerber J, Sandhoff K (1997) Turnover of endogenous ceramide in cultured normal and Farber fibroblasts. J Lipid Res 38:2569-2579
34. Zappatini-Tommasi L, Dumontel C, Guibaud P, Girod C (1992) Farber disease: an ultrastructural study. Report of a case and review of the literature. Virchows Arch [A] 420:281-290